South Korea's Celltrion aims to start in-human COVID-19 drug trial in July

South Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated an up to 100-fold reduction in viral load of the disease in animal testing, saying it aims to start in-human clinical trials in late July.

from Reuters: Health News https://ift.tt/3eD7408
via IFTTT